Search research articles
Contact Us
Filters
Showing results (161-170 of 357) with videos related to
Page
of 36
Sort By:
Complementary Therapies in Clinical Practice
|
July 13, 2010
The use of complementary and alternative medicine by patients with chronic hepatitis C
Jacqueline A Richmond, Donald E Bailey, Keyur Patel, et al.
Gastroenterology
|
February 24, 2010
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
Jeanette J McCarthy, Josephine H Li, Alexander Thompson, et al.
Antiviral Therapy
|
December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients
Keyur Patel, Seng G Lim, Chow W Cheng, et al.
Journal of Hepatology
|
May 5, 2004
The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients
Heather M Patton, Keyur Patel, Cynthia Behling, et al.
Hepatology (Baltimore, Md.)
|
January 28, 2006
HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C
Keyur Patel, Suzanne Norris, Lauralynn Lebeck, et al.
Journal of Gastroenterology and Hepatology
|
February 27, 2003
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C
Keyur Patel, Adrianne Lajoie, Shanon Heaton, et al.
American Journal of Hematology
|
October 12, 2016
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML)
Preetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2014
Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C
Keyur Patel, Katja S Remlinger, Terence G Walker, et al.
NPJ Precision Oncology
|
December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Niamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
March 5, 2019
Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure
Veeral Ajmera, Hailiang Huang, Doan Dao, et al.
Page
of 36
Search research articles
Search
Showing results (161-170 of 357) with videos related to
Sort By:
Page
of 36
Complementary Therapies in Clinical Practice
|
July 13, 2010
The use of complementary and alternative medicine by patients with chronic hepatitis C
Jacqueline A Richmond, Donald E Bailey, Keyur Patel, et al.
Gastroenterology
|
February 24, 2010
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
Jeanette J McCarthy, Josephine H Li, Alexander Thompson, et al.
Antiviral Therapy
|
December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients
Keyur Patel, Seng G Lim, Chow W Cheng, et al.
Journal of Hepatology
|
May 5, 2004
The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients
Heather M Patton, Keyur Patel, Cynthia Behling, et al.
Hepatology (Baltimore, Md.)
|
January 28, 2006
HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C
Keyur Patel, Suzanne Norris, Lauralynn Lebeck, et al.
Journal of Gastroenterology and Hepatology
|
February 27, 2003
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C
Keyur Patel, Adrianne Lajoie, Shanon Heaton, et al.
American Journal of Hematology
|
October 12, 2016
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML)
Preetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2014
Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C
Keyur Patel, Katja S Remlinger, Terence G Walker, et al.
NPJ Precision Oncology
|
December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Niamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
March 5, 2019
Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure
Veeral Ajmera, Hailiang Huang, Doan Dao, et al.
Page
of 36